A systematic review on hydroxyurea therapy for sickle cell disease in India

BACKGROUND & OBJECTIVES: Sickle cell disease (SCD) constitutes frequently inherited haemoglobin disorders and poses a significant health burden in India. Hydroxyurea (HU), the most commonly used drug, has shown promising results in the clinical management of SCD. The present systematic review wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Apoorva, Kaur, Harpreet, Borah, Sapan, Khargekar, Naveen, Karra, Vijay Kumar, Adhikari, Tulsi, Jain, Dipty, Madkaikar, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Practice: Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057355/
https://www.ncbi.nlm.nih.gov/pubmed/36629190
http://dx.doi.org/10.4103/ijmr.ijmr_3447_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057355/
https://www.ncbi.nlm.nih.gov/pubmed/36629190
http://dx.doi.org/10.4103/ijmr.ijmr_3447_21

Ejemplares similares